GlassScriptPhysician profile
Mark A Birmingham
NPI 1396913117
$6,508.56
in general payments reported to CMS, 2019-2025
29 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,192 · 2020: $386 · 2021: $1,406 · 2022: $481 · 2023: $259 · 2024: $747 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661 · Travel and Lodging: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,660.99 |
| Travel and Lodging | $382.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $2,503.20 | 2019-2025 | |
| Arthrex, INC. | $877.00 | 2019-2025 | |
| Paragon 28, INC. | $511.96 | 2022-2024 | Portfolio, Precision Mis Bunion, Monkey Rings |
| Integra Lifesciences Corporation | $436.98 | 2019-2020 | |
| Smith+Nephew, INC. | $249.07 | 2019-2023 | Evos Mini, Integra Movement Great Toe System, Hat-Trick |
| Depuy Synthes Sales INC. | $209.06 | 2022-2025 | Na, Motoband, Orthovisc |
| Bioventus LLC | $186.91 | 2019-2024 | Exogen Ultrasound Bone Healing System, Gelsyn-3, Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $176.57 | 2022-2025 | |
| Access Pro Medical, LLC | $168.26 | 2025 | Matriderm |
| Linvatec Corporation | $148.20 | 2024-2025 | Biobrace 23mm, Hercules Suture Anchor System, Quantum |
| Medline Industries LP | $140.00 | 2021 | |
| Averitas Pharma INC. | $116.57 | 2024-2025 | Qutenza |
| Triad Life Sciences INC. | $109.64 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $102.64 | 2021-2024 | |
| Osiris Therapeutics INC. | $93.80 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $86.24 | 2022-2025 | Easyfuse, Ortholoc 3di |
| Orthofix Medical, INC. | $56.86 | 2020-2025 | Physio-Stim |
| Dentsply Sirona INC | $46.64 | 2023 | Astra Tech Implant System |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $45.87 | 2024-2025 | Jublia |
| Medtronic, INC. | $45.36 | 2023-2025 | In.Pact Admiral, Stealthstation S8 Platform |
| Horizon Therapeutics Plc | $40.11 | 2019-2023 | Krystexxa |
| Acumed LLC | $32.21 | 2019-2022 | |
| Endo USA, INC. | $26.57 | 2025 | Xiaflex |
| Osteomed LLC | $25.51 | 2020 | |
| Biotissue Holdings INC. | $21.34 | 2024 | |
| Arteriocyte Medical Systems, INC. | $16.07 | 2019 | |
| Acera Surgical, INC. | $15.69 | 2023 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $12.10 | 2019 | |
| Kerecis Limited | $8.13 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Birmingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.